Results 31 to 40 of about 782,827 (325)

Hematological Abnormalities in Patients With COVID-19: An Emerging Approach to Differentiate Between Severe COVID-19; Compared With Non-Severe Forms of the Disease

open access: yesActa Medica Iranica, 2021
The 2019 novel coronavirus (2019-nCoV) or the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has emerged as a pandemic threat from December 2019.
Mahdieh Mehrpouri
doaj   +1 more source

Economy or Health, Constant Dilemma in Times of Pandemic: The Case of Coronavirus Disease 2019 (COVID-19)

open access: yesJournal of Pure and Applied Microbiology, 2020
The multiple faces of the Coronavirus Disease 2019 (COVID-19), also included the impact on the economy. As a consequence of the significant life and society disruption, multiple implications are derived from the COVID-19 crisis and pandemic, including ...
Jorge A. Sanchez-Duque   +6 more
doaj   +1 more source

A Case Report of Coronavirus Disease 2019 Presenting with Tremors and Gait Disturbance [PDF]

open access: yes, 2020
Introduction: Neurologic symptoms present as significant complications of coronavirus disease 2019 (COVID-19) infection. This report describes a novel manifestation of tremors triggered by severe acute respiratory syndrome coronavirus 2 infection.Case ...
Berman, Adam   +5 more
core   +2 more sources

Coronavirus disease 2019 (COVID-19) in Autoimmune Hepatitis

open access: yesHepatology Forum, 2022
Severe acute respiratory syndrome coronavirus 2 is a highly transmissible and pathogenic virus that leads to coronavirus disease 2019 (COVID-19). The preexisting liver diseases alter the course of COVID-19. Therefore, specific management strategies must be considered in individuals with chronic liver diseases (CLDs) and COVID-19.
Nur Dagli, Seyda, Efe, Cumali
openaire   +2 more sources

The Incubation Period of Coronavirus Disease 2019 (COVID-19) From Publicly Reported Confirmed Cases: Estimation and Application

open access: yesAnnals of Internal Medicine, 2020
Background: A novel human coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), was identified in China in December 2019. There is limited support for many of its key epidemiologic features, including the incubation period for ...
S. Lauer   +8 more
semanticscholar   +1 more source

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges

open access: yesInternational Journal of Antimicrobial Agents, 2020
The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2; previously provisionally named 2019 novel coronavirus or 2019-nCoV) disease (COVID-19) in China at the end of 2019 has caused a large global outbreak and is a major public ...
Chih-Cheng Lai   +4 more
semanticscholar   +1 more source

Environmental Determinants of Coronavirus Disease 2019 (COVID-19) [PDF]

open access: yesCurrent Allergy and Asthma Reports, 2021
Since the coronavirus SARS-CoV-2 outbreak in China in late 2019 turned into a global pandemic, numerous studies have reported associations between environmental factors, such as weather conditions and a range of air pollutants (particulate matter, nitrogen dioxide, ozone, etc.) and the first wave of COVID-19 cases.
Eric B. Brandt, Tesfaye B. Mersha
openaire   +2 more sources

Coronavirus Disease 2019 (COVID–19): A Short Review on Hematological Manifestations

open access: yesPathogens, 2020
Infection with severe acute respiratory syndrome coronavirus 2 (SARS–CoV–2) is a rapidly spreading and devastating global pandemic. Many researchers are attempting to clarify the mechanisms of infection and to develop a drug or vaccine against the virus,
Artur Słomka   +2 more
doaj   +1 more source

The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak – an update on the status

open access: yesMilitary Medical Research, 2020
An acute respiratory disease, caused by a novel coronavirus (SARS-CoV-2, previously known as 2019-nCoV), the coronavirus disease 2019 (COVID-19) has spread throughout China and received worldwide attention.
Yanrong Guo   +8 more
semanticscholar   +1 more source

Nanotechnology‐facilitated vaccine development during the coronavirus disease 2019 (COVID‐19) pandemic

open access: yesExploration, 2022
Coronavirus disease 2019 (COVID‐19) continually poses a significant threat to the human race, and prophylactic vaccination is the most potent approach to end this pandemic.
Ziqi Wang   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy